IN8BIO, INC. Increase (Decrease) in Other Current Liabilities
IN8BIO, INC. (INAB) reported Increase (Decrease) in Other Current Liabilities of -$872.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2026-08-06
- IN8BIO, INC. increase (decrease) in other current liabilities for the quarter ending 2026-06-30 was $80.00K.
- IN8BIO, INC. increase (decrease) in other current liabilities for the quarter ending 2026-03-31 was -$952.00K, a 1071.43% decline year-over-year.
- IN8BIO, INC. increase (decrease) in other current liabilities for the quarter ending 2025-12-31 was $1.22M, a 340.22% increase year-over-year.
- IN8BIO, INC. increase (decrease) in other current liabilities for the quarter ending 2025-09-30 was -$217.00K.
- IN8BIO, INC. increase (decrease) in other current liabilities for fiscal 2025 was $586.00K.
- IN8BIO, INC. increase (decrease) in other current liabilities for fiscal 2024 was -$1.91M, a 339.70% decline from fiscal 2023.
- IN8BIO, INC. increase (decrease) in other current liabilities for fiscal 2023 was $796.00K, a 13.85% decline from fiscal 2022.
- IN8BIO, INC. increase (decrease) in other current liabilities for fiscal 2022 was $924.00K, a 66.79% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month | Increase (Decrease) in Other Current Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$872.00K 10-Q · filed 2026-08-06 | $343.00K derived: sum of 3 quarters · filed 2026-08-06 | $126.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$952.00K 10-Q · filed 2026-05-07 | $263.00K derived: sum of 2 quarters · filed 2026-05-07 | $46.00K derived: sum of 3 quarters · filed 2026-05-07 | -$464.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $998.00K derived: sum of 2 quarters · filed 2026-03-12 | $488.00K derived: sum of 3 quarters · filed 2026-08-06 | $586.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | -$217.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$727.00K derived: sum of 2 quarters · filed 2026-08-06 | -$629.00K 10-Q · filed 2025-11-06 | -$353.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$412.00K 10-Q · filed 2026-08-06 | -$136.00K derived: sum of 3 quarters · filed 2026-08-06 | -$898.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $98.00K 10-Q · filed 2026-05-07 | $374.00K derived: sum of 2 quarters · filed 2026-05-07 | -$388.00K derived: sum of 3 quarters · filed 2026-05-07 | $250.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$486.00K derived: sum of 2 quarters · filed 2026-03-12 | $152.00K derived: sum of 3 quarters · filed 2026-03-12 | -$1.91M 10-K · filed 2026-03-12 | |
| 2024-09-30 | -$762.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$124.00K derived: sum of 2 quarters · filed 2025-11-06 | -$2.18M 10-Q · filed 2025-11-06 | -$1.67M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $638.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.42M 10-Q · filed 2025-08-07 | -$906.00K derived: sum of 3 quarters · filed 2025-08-07 | -$141.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | -$2.06M 10-Q · filed 2025-05-07 | -$1.54M derived: sum of 2 quarters · filed 2025-05-07 | -$779.00K derived: sum of 3 quarters · filed 2025-05-07 | -$597.00K derived: sum of 4 quarters · filed 2025-05-07 | |
| 2023-12-31 | $516.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $1.28M derived: sum of 2 quarters · filed 2025-03-13 | $1.46M derived: sum of 3 quarters · filed 2025-03-13 | $796.00K 10-K · filed 2025-03-13 | |
| 2023-09-30 | $765.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $947.00K derived: sum of 2 quarters · filed 2024-11-12 | $280.00K 10-Q · filed 2024-11-12 | $235.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$485.00K 10-Q · filed 2024-08-08 | -$530.00K derived: sum of 3 quarters · filed 2024-08-08 | $149.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$667.00K 10-Q · filed 2024-05-09 | -$712.00K derived: sum of 2 quarters · filed 2024-05-09 | -$33.00K derived: sum of 3 quarters · filed 2024-05-09 | $608.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | -$45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $634.00K derived: sum of 2 quarters · filed 2024-03-14 | $1.27M derived: sum of 3 quarters · filed 2024-03-14 | $924.00K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $679.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.32M derived: sum of 2 quarters · filed 2023-11-09 | $969.00K 10-Q · filed 2023-11-09 | $2.46M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $641.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $290.00K 10-Q · filed 2022-08-12 | $1.78M derived: sum of 3 quarters · filed 2023-05-12 | $1.06M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2022-03-31 | -$351.00K 10-Q · filed 2023-05-12 | $1.14M derived: sum of 2 quarters · filed 2023-05-12 | $424.00K derived: sum of 3 quarters · filed 2023-05-12 | $501.00K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $775.00K derived: sum of 2 quarters · filed 2023-03-30 | $852.00K derived: sum of 3 quarters · filed 2023-03-30 | $554.00K 10-K · filed 2023-03-30 | -$554.00K 10-K · filed 2022-03-17 |
| 2021-09-30 | -$717.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$640.00K derived: sum of 2 quarters · filed 2022-11-10 | -$938.00K 10-Q · filed 2022-11-10 | -$938.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$221.00K 10-Q · filed 2022-08-12 | -$221.00K derived: sum of 3 quarters · filed 2022-08-12 | -$596.00K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$298.00K 10-Q · filed 2022-05-12 | -$298.00K derived: sum of 2 quarters · filed 2022-05-12 | -$673.00K derived: sum of 3 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$375.00K derived: sum of 2 quarters · filed 2022-03-17 | $816.00K 10-K · filed 2022-03-17 | ||
| 2020-09-30 | -$375.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $816.00K 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $1.19M 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |